SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Jun 15, 2018
Document Date
Jun 13, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Altimmune
Issuer
ALTIMMUNE, INC.
Filer
NOVARTIS AG
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe